Evolution of bla KPC Under the Pressure of Carbapenems and Ceftazidime/Avibactam in a Patient With Persistent Bacteremia Caused by Klebsiella pneumoniae-Reference-Cited by-同舟云学术

Evolution of bla _KPC Under the Pressure of Carbapenems and Ceftazidime/Avibactam in a Patient With Persistent Bacteremia Caused by Klebsiella pneumoniae

Published:2024 Issue:25 Volume:39 Page:
ISSN:1011-8934
Container-title:Journal of Korean Medical Science
language:en
Short-container-title:J Korean Med Sci

Author:

Won Eun Jeong¹^ORCID,Park Kuenyoul²^ORCID,Jeong Yun Sil¹^ORCID,Kim Jiyeon¹^ORCID,Choi Yunsuk³^ORCID,Kim Sung-Han⁴^ORCID,Kim Mi-Na¹^ORCID,Sung Heungsup¹^ORCID

Affiliation:

1. Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

2. Department of Laboratory Medicine, Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea.

3. Division of Hematology, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

4. Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

Funder

National Research Foundation of Korea

Publisher

XMLink

Link

https://jkms.org/pdf/10.3346/jkms.2024.39.e208

Reference22 articles.

1. Elevated Mortality Risk from CRKp Associated with Comorbidities: Systematic Review and Meta-Analysis

2. Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae

3. Carbapenemase-Producing Organisms: A Global Scourge

4. Inhibitor Resistance in the KPC-2 β-Lactamase, a Preeminent Property of This Class A β-Lactamase

5. Review of Ceftazidime-Avibactam, Meropenem-Vaborbactam, and Imipenem/Cilastatin-Relebactam to Target Klebsiella pneumoniae Carbapenemase-Producing Enterobacterales